PRE-MARKET INDIAN STOCK NEWS: Ashok Leyland (AL IS) Q4 (INR) net rose 14% Y/Y to INR 12.91bln

Newsquawk StaffPublished On the live feed at 1 more headline followed before this page went public
Newsquawk headlinesUTC

Fuel storage facilities in Russia’s Yaroslavl region were hit by drones

China will retaliate against EU's overcapacity tool and may probe EU supply chains, according to state-linked Yu Yuantan

PRE-MARKET INDIAN STOCK NEWS: Ashok Leyland (AL IS) Q4 (INR) net rose 14% Y/Y to INR 12.91bln

Japan sells JPY 2.1tln 2-year JGBs b/c 3.70 (prev. 5.24), average yield 1.369% (prev. 1.407%)

[MARKET ANALYSIS] Asia-Pac stocks head into month-end mostly on the front foot after reports of a tentative agreement for a US-Iran ceasefire extension

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Ashok Leyland (AL IS) - Co. Q4 (INR) net rose 14.2% Y/Y to INR 12.91bln, rev. rose 17.4% Y/Y to INR 172.46bln. (Moneycontrol)

Coal India (COAL IS) - Co. said the government will exercise the oversubscription option in its offer-for-sale amid strong investor interest and will now sell up to 12.32 crore shares, representing 2% of the Co.’s total paid-up equity share capital. (Economic Times)

GMR Airports (GMRI IS) - Co. Q4 (INR) net INR 3.02bln (prev. loss Y/Y), rev. rose 37.5% Y/Y to INR 39.38bln. (Moneycontrol)

IDFC First Bank (IDFCFIRSTB IS) - Co. received INR 5.15bln from the Credit Guarantee Fund for Micro Units scheme against claims on its microfinance portfolio. (Economic Times)

Lupin (LPC IS) - Co. received the Establishment Inspection Report from the US FDA for its Ankleshwar facility in Gujarat following the closure of a product-specific pre-approval inspection. (Moneycontrol)

Reliance Industries (RIL IS) - Co. scheduled its 49th AGM for June 19, 2026. (Economic Times)

Wipro (WPRO IS) - Co. expanded its partnership with ServiceNow to implement and scale agentic AI workflows across core enterprise functions. (Moneycontrol)

Zydus Lifesciences (CDH IS) - Co.’s unit Zydus Therapeutics received US FDA priority review for its New Drug Application for saroglitazar. (Economic Times)

Related headlines

The whole workspace, free to try.

Try it free